BIIB
BIOGEN INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$215.50
−1.62%Forward multiples
Based on analyst estimates
- P/E forward
- 16.26x
- P/E 2026E
- 17.44x
- P/E 2027E
- 13.09x
- P/E 2028E
- 11.59x
- P/S forward
- 3.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.94x
- PEG TTM
- 0.29x
- Price / book
- 1.69x
- Price / sales
- 3.20x
- Price / cash flow
- 11.06x
Enterprise value
- Enterprise value
- $38.9B
- EV / sales
- 3.91x
- EV / EBITDA
- 23.29x
- EV / EBIT
- 30.58x
- Market cap
- $31.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026